Condition
CART Therapy clinical trials and research
As of November 12, 2026, Find a Trial lists 5 CART Therapy clinical trials that are recruiting, at sites in 4 countries (most in China (2), Australia (1), United States (1)). By phase: Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest CART Therapy clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Cognitive changes after BCMA CAR-T in multiple myeloma | — | Charlotte, North Carolina | Recruiting | Jul 31, 2026 |
| Geriatric assessment before CAR‑T or bispecific antibody therapy to predict side effects and outcomes in older adults | — | Bern and 1 other locations | Recruiting | Dec 30, 2025 |
| Early versus late stopping of antibiotics for adults with high‑risk blood cancers or after stem‑cell or CAR T therapy who develop fever | — | Melbourne, Victoria and 1 other locations | Recruiting | Jul 4, 2025 |
| Cell injection for patients with relapsed or refractory CD7-positive NK/T cell malignancies | Phase 1 | Wuhan, Hubei | Recruiting | Dec 13, 2024 |
| Comparing immunotherapy bridging treatment to standard therapy in low-risk B-NHL patients | Phase 2 | Shanghai, Shanghai Municipality | Recruiting | Nov 19, 2024 |
All recruiting trials (5)
-
Cognitive changes after BCMA CAR-T in multiple myeloma
This study tests whether cognitive function changes over time in adults with relapsed or refractory multiple myeloma who receive BCMA CAR-T therapy.
-
Geriatric assessment before CAR‑T or bispecific antibody therapy to predict side effects and outcomes in older adults
This study will test whether a brief geriatric assessment done before CAR‑T or bispecific antibody treatment can help predict side effects and outcomes for people aged 65 and older with aggressive lymphoma or multiple myeloma.
-
Early versus late stopping of antibiotics for adults with high‑risk blood cancers or after stem‑cell or CAR T therapy who develop fever
This trial tests if stopping antibiotics early is safe for adults with leukemia or after stem‑cell transplant or CAR T therapy when a fever has settled.
-
Cell injection for patients with relapsed or refractory CD7-positive NK/T cell malignancies
This study is testing a new cell therapy for people with hard-to-treat CD7-positive NK/T cell lymphoma to see if it is safe and helps improve their condition.
-
Comparing immunotherapy bridging treatment to standard therapy in low-risk B-NHL patients
This study is testing whether adding an immunotherapy treatment with zanubrutinib helps people with low-risk B-cell non-Hodgkin lymphoma feel better compared to those who don’t get this extra treatment.
Related topics
Quick answers
How many CART Therapy clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (2 trials), Australia (1 trial), United States (1 trial), Switzerland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.